Phase 2 Readout
CANF: Phase 2 Readout: namodenoson
September 30, 2026 · namodenoson. BioSniper AI can trace the company-impact path without requiring you to write the research question.
- Event date
- September 30, 2026
- Company
- Can-Fite BioPharma Ltd. (CANF)
- Drug
- namodenoson
BioSniper AIPage evidence connected
Prepared research question
What could this event change, and which evidence should be watched next?
Run cited research
Traceable citations · Unknowns marked
Phase 2 Readout~quarter
Phase 2 Readout: namodenoson
- Drug
- namodenoson
- Indication
- pancreatic cancer